Book Online or Call 1-855-SAUSALITO

Sign In  |  Register  |  About Sausalito  |  Contact Us

Sausalito, CA
September 01, 2020 1:41pm
7-Day Forecast | Traffic

  • Search Hotels in Sausalito

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

AbbVie (NY:ABBV)

209.15 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EDT, Aug 20, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about AbbVie

< Previous 1 2 3 4 5 6 7 8 9
...
76 77 Next >
Q2 Earnings Highlights: AbbVie (NYSE:ABBV) Vs The Rest Of The Therapeutics Stocks
Earnings results often indicate what direction a company will take in the months ahead. With Q2 behind us, let’s have a look at AbbVie (NYSE:ABBV) and its peers. 
Via StockStory
Topics Artificial Intelligence
Jackson Hole Symposium Looms: Why Investors Are Holding Their Breath for Powell's Remarks
The financial world is abuzz with anticipation as the annual Jackson Hole Economic Symposium draws near, an exclusive gathering hosted by the Federal Reserve Bank of Kansas City in the serene mountains... 
Via MarketMinute
Topics Bonds Climate Change Economy
Federal Reserve Poised for September Rate Cut Amidst High Market Expectations and Powell's Jackson Hole Address
Investor sentiment is overwhelmingly pointing towards a significant shift in the Federal Reserve's monetary policy, with a near-certainty of a 25-basis-point interest rate cut anticipated at its... 
Via MarketMinute
Topics Bonds Credit Cards Economy
If You'd Invested $1,000 in AbbVie Stock 10 Years Ago, Here's How Much You'd Have Today
You'd be sitting pretty right now. 
Via The Motley Fool
Topics Intellectual Property
Marjorie Taylor Greene Keeps Buying UnitedHealth Stock Along With Fellow Investors Buffett And Burry
Marjorie Taylor Greene may have another winning stock trade with a new filing showing a purchase of UnitedHealth stock. 
Via Benzinga
Here's How Much $100 Invested In AbbVie 5 Years Ago Would Be Worth Today
 
Via Benzinga
3 Dividend Stocks to Double Up On Right Now
These stocks offer great dividends and more. 
Via The Motley Fool
Topics Economy Government World Trade
1 Cash-Producing Stock with Exciting Potential and 2 We Avoid
A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand. 
Via StockStory
Topics Economy
If You'd Invested $1,000 in AbbVie (ABBV) Stock 10 Years Ago, Here's How Much You'd Have Today
Via The Motley Fool
Expert Outlook: AbbVie Through The Eyes Of 4 Analysts
 
Via Benzinga
Fed Rate Cut Hopes Fuel Market Rally: Inflation Data Steers September Expectations
Optimism has surged through financial markets as recent economic data, particularly the July Consumer Price Index (CPI), has significantly bolstered expectations for a 25-basis-point interest rate cut... 
Via MarketMinute
Topics Bonds Credit Cards Economy
These S&P500 stocks are moving in today's session
Curious about the S&P500 stocks that are in motion on Thursday? Join us as we explore the top movers within the S&P500 index during today's session. 
Via Chartmill
Inflation Report Sparks Global Rally: How Tame CPI is Reshaping Market Expectations
A surprisingly subdued July Consumer Price Index (CPI) report has sent ripples of optimism across global financial markets, igniting a worldwide rally and significantly recalibrating expectations for... 
Via MarketMinute
Topics Bonds Credit Cards Economy
ABBV Q2 Deep Dive: Immunology and Neuroscience Growth Outpace Aesthetics, Guidance Trimmed
Pharmaceutical company AbbVie (NYSE:ABBV) reported revenue ahead of Wall Street’s expectations in Q2 CY2025, with sales up 6.6% year on year to $15.42 billion. Its non-GAAP profit of $2.97 per share... 
Via StockStory
My 3 Favorite Stocks to Buy Right Now
These tried-and-true businesses are performing well against a volatile backdrop. 
Via The Motley Fool
Topics Intellectual Property
4 of My Favorite Dividend Stocks for the Next 5 Years
All four pay safe, reliable, and growing dividends. 
Via The Motley Fool
3 Stocks Retirees Should Absolutely Love
These stocks check off all the boxes for investors no longer receiving a paycheck. 
Via The Motley Fool
Topics Economy Retirement
Is the Vanguard Value ETF the Simplest Way to Consistently Collect More Passive Income Than the S&P 500?
This ultra-low-cost ETF is an excellent way to invest in large-cap value stocks, many of which pay dividends. 
Via The Motley Fool
Topics ETFs Regulatory Compliance Stocks
3 Market-Beating Stocks with Solid Fundamentals
The best-performing stocks typically have robust sales growth, increasing margins, and rising returns on capital, and those that can maintain this trifecta year in and year out often become the legends... 
Via StockStory
AbbVie Inclusion In Medicare Drug Talks Fails To Justify Lawsuit, Court Rules
The federal court dismissed a lawsuit from business chambers over the Medicare drug price negotiation program. 
Via Benzinga
Topics Lawsuit
Federal Reserve Poised for Rate Cuts as Economic Headwinds Mount, Tariffs Complicate Outlook
Financial markets are currently pricing in a high likelihood of the Federal Reserve initiating interest rate cuts before the year-end, a significant shift in monetary policy that reflects growing... 
Via MarketMinute
Topics Bankruptcy Economy Government
Genmab/AbbVie Partnered Blood Cancer Combination Drug Cuts Risk Of Disease Progression By 79%
Genmab reported strong Phase 3 trial results for epcoritamab in FL, secured FDA priority review, and raised its 2025 sales outlook after Q2 beat. 
Via Benzinga
Trump Threatens Pharma With Potential 250% Tariffs In 18 Months: 'We Want Pharmaceuticals Made In Our Country'
President Donald Trump has indicated the possibility of imposing tariffs on imported pharmaceuticals that could rise up to 250%, indicating the highest rate he has proposed so far. 
Via Benzinga
Topics Government World Trade
1 S&P 500 Stock with Competitive Advantages and 2 We Brush Off
The S&P 500 (^GSPC) is often seen as a benchmark for strong businesses, but that doesn’t mean every stock is worth owning. Some companies face significant challenges, whether it’s stagnating growth,... 
Via StockStory
Topics Stocks
AbbVie (ABBV) Q2 2025 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
AbbVie Raises 2025 Outlook After Q2 Beat
Via The Motley Fool
Pfizer's Ascent Signals Broader Health Sector Resilience Amidst Innovation Wave
In a notable shift, shares of Pfizer (NYSE: PFE) have recently edged higher, reflecting a burgeoning strength within the broader health sector. This uptick signals a renewed investor confidence in the... 
Via MarketMinute
Topics Artificial Intelligence Economy Intellectual Property
Nuclear Threats, Trump Fires Labor Statistics Chief, Fed Governor Resigns And More: This Week In Politics
 
Via Benzinga
Topics Economy Government
3 Unstoppable Stocks to Buy in August
Here are hot stocks to buy in a hot month. 
Via The Motley Fool
Topics Intellectual Property
3 Dividend Champion Stocks I'm Watching in 2025
Other investors might want to watch these high-yield dividend stocks, too. 
Via The Motley Fool
Topics Earnings Government World Trade
< Previous 1 2 3 4 5 6 7 8 9
...
76 77 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Photos copyright by Jay Graham Photographer
Copyright © 2010-2020 Sausalito.com & California Media Partners, LLC. All rights reserved.